SSPedi<\/h1><\/div><\/div><\/div><\/div><\/div>![\"SSPedi](\"https:\/\/lab.research.sickkids.ca\/sung\/wp-content\/uploads\/sites\/153\/2024\/11\/SSPedi-Logo.png\" "\\"SSPedi")
<\/span><\/div><\/div><\/div>SSPedi is a 15 item symptom screening tool for children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change in children 8-18 years.<\/p>\n<\/div>
Key publications<\/h2><\/div>Dupuis, L. L., Johnston, D. L., Baggott, C., et al. (2018). Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.<\/a> Journal of the National Cancer Institute, 110(6), 661\u2013668. https:\/\/doi.org\/10.1093\/jnci\/djx250<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>To see current versions, please see Tools<\/a>.<\/p>\n<\/div><\/div><\/div><\/div><\/div>Proxy SSPedi<\/h2>\n<\/div>Proxy SSPedi is a 15 item symptom screening tool for guardians of children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change for parents or guardians of children 2-18 years.<\/p>\n<\/div>
Key publications<\/h3>\n<\/div>Hyslop S, Dupuis LL, Baggott C, et al. Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.<\/a> J Pain Symptom Manage. 2018 Jul;56(1):107-112. doi: 10.1016\/j.jpainsymman.2018.03.025. Epub 2018 Apr 6. PMID: 29630923.<\/p>\n<\/div><\/div><\/div>Mini SSPedi<\/h2>\n<\/div>Mini SSPedi is a 15 item symptom screening tool for children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change in children 4-7 years.<\/p>\n<\/div>
Key publications<\/h3>\n<\/div>Tomlinson, D., Dupuis, L.L., Johnston, D.L. et al. Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7\u2009years receiving cancer treatments.<\/a> BMC Cancer 22, 730 (2022). https:\/\/doi.org\/10.1186\/s12885-022-09814-8<\/p>\n<\/div><\/div><\/div>Co-SSPedi<\/h2>\n<\/div>Co-SSPedi is a dyadic (child-guardian) 15 item symptom screening tool for children and their guardians for children receiving cancer treatment and undergoing hematopoietic stem cell transplant, and their guardians; it is reliable, valid and responsive to change in children 4-7 years (co-mini SSPedi) and 8-18 years (co-SSPedi).<\/p>\n<\/div>
Key publications<\/h3>\n<\/div>Tomlinson D, Dupuis LL, Dix D, Crellin-Parsons N, Cook S, Kulkarni K, Schechter T, Tomlinson GA, Sung L. Validation of co-Symptom Screening in Pediatrics Tool: a novel dyadic approach to symptom screening in pediatric patients receiving cancer treatment.<\/a> J Natl Cancer Inst. 2024 Jan 10;116(1):160-166. doi: 10.1093\/jnci\/djad181. PMID: 37672037.<\/p>\n<\/div><\/div><\/div><\/div><\/div>Translating SSPedi<\/h2><\/div>If you are interested in translating and validation SSPedi into another language, please reach out to sung.research@sickkids.ca<\/a>. The following translation validation paper can be used for reference.<\/p>\n<\/div>
<\/span><\/div><\/div><\/div>SSPedi is a 15 item symptom screening tool for children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change in children 8-18 years.<\/p>\n<\/div>
Key publications<\/h2><\/div>Dupuis, L. L., Johnston, D. L., Baggott, C., et al. (2018). Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.<\/a> Journal of the National Cancer Institute, 110(6), 661\u2013668. https:\/\/doi.org\/10.1093\/jnci\/djx250<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>To see current versions, please see Tools<\/a>.<\/p>\n<\/div><\/div><\/div><\/div><\/div>Proxy SSPedi<\/h2>\n<\/div>Proxy SSPedi is a 15 item symptom screening tool for guardians of children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change for parents or guardians of children 2-18 years.<\/p>\n<\/div>
Key publications<\/h3>\n<\/div>Hyslop S, Dupuis LL, Baggott C, et al. Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.<\/a> J Pain Symptom Manage. 2018 Jul;56(1):107-112. doi: 10.1016\/j.jpainsymman.2018.03.025. Epub 2018 Apr 6. PMID: 29630923.<\/p>\n<\/div><\/div><\/div>Mini SSPedi<\/h2>\n<\/div>Mini SSPedi is a 15 item symptom screening tool for children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change in children 4-7 years.<\/p>\n<\/div>
Key publications<\/h3>\n<\/div>Tomlinson, D., Dupuis, L.L., Johnston, D.L. et al. Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7\u2009years receiving cancer treatments.<\/a> BMC Cancer 22, 730 (2022). https:\/\/doi.org\/10.1186\/s12885-022-09814-8<\/p>\n<\/div><\/div><\/div>Co-SSPedi<\/h2>\n<\/div>Co-SSPedi is a dyadic (child-guardian) 15 item symptom screening tool for children and their guardians for children receiving cancer treatment and undergoing hematopoietic stem cell transplant, and their guardians; it is reliable, valid and responsive to change in children 4-7 years (co-mini SSPedi) and 8-18 years (co-SSPedi).<\/p>\n<\/div>
Key publications<\/h3>\n<\/div>Tomlinson D, Dupuis LL, Dix D, Crellin-Parsons N, Cook S, Kulkarni K, Schechter T, Tomlinson GA, Sung L. Validation of co-Symptom Screening in Pediatrics Tool: a novel dyadic approach to symptom screening in pediatric patients receiving cancer treatment.<\/a> J Natl Cancer Inst. 2024 Jan 10;116(1):160-166. doi: 10.1093\/jnci\/djad181. PMID: 37672037.<\/p>\n<\/div><\/div><\/div><\/div><\/div>Translating SSPedi<\/h2><\/div>If you are interested in translating and validation SSPedi into another language, please reach out to sung.research@sickkids.ca<\/a>. The following translation validation paper can be used for reference.<\/p>\n<\/div>
Dupuis, L. L., Johnston, D. L., Baggott, C., et al. (2018). Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.<\/a> Journal of the National Cancer Institute, 110(6), 661\u2013668. https:\/\/doi.org\/10.1093\/jnci\/djx250<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div> To see current versions, please see Tools<\/a>.<\/p>\n<\/div><\/div><\/div><\/div><\/div> Proxy SSPedi is a 15 item symptom screening tool for guardians of children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change for parents or guardians of children 2-18 years.<\/p>\n<\/div> Hyslop S, Dupuis LL, Baggott C, et al. Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.<\/a> J Pain Symptom Manage. 2018 Jul;56(1):107-112. doi: 10.1016\/j.jpainsymman.2018.03.025. Epub 2018 Apr 6. PMID: 29630923.<\/p>\n<\/div><\/div><\/div> Mini SSPedi is a 15 item symptom screening tool for children receiving cancer treatment and undergoing hematopoietic stem cell transplant; it is reliable, valid and responsive to change in children 4-7 years.<\/p>\n<\/div> Tomlinson, D., Dupuis, L.L., Johnston, D.L. et al. Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7\u2009years receiving cancer treatments.<\/a> BMC Cancer 22, 730 (2022). https:\/\/doi.org\/10.1186\/s12885-022-09814-8<\/p>\n<\/div><\/div><\/div> Co-SSPedi is a dyadic (child-guardian) 15 item symptom screening tool for children and their guardians for children receiving cancer treatment and undergoing hematopoietic stem cell transplant, and their guardians; it is reliable, valid and responsive to change in children 4-7 years (co-mini SSPedi) and 8-18 years (co-SSPedi).<\/p>\n<\/div> Tomlinson D, Dupuis LL, Dix D, Crellin-Parsons N, Cook S, Kulkarni K, Schechter T, Tomlinson GA, Sung L. Validation of co-Symptom Screening in Pediatrics Tool: a novel dyadic approach to symptom screening in pediatric patients receiving cancer treatment.<\/a> J Natl Cancer Inst. 2024 Jan 10;116(1):160-166. doi: 10.1093\/jnci\/djad181. PMID: 37672037.<\/p>\n<\/div><\/div><\/div><\/div><\/div> If you are interested in translating and validation SSPedi into another language, please reach out to sung.research@sickkids.ca<\/a>. The following translation validation paper can be used for reference.<\/p>\n<\/div>Proxy SSPedi<\/h2>\n<\/div>
Key publications<\/h3>\n<\/div>
Mini SSPedi<\/h2>\n<\/div>
Key publications<\/h3>\n<\/div>
Co-SSPedi<\/h2>\n<\/div>
Key publications<\/h3>\n<\/div>
Translating SSPedi<\/h2><\/div>